Driehaus Capital Management LLC 13D and 13G filings for Xenon Pharmaceuticals Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-14 07:43 am Sale | 2023-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE | Driehaus Capital Management LLC | 4,345,180 5.880% | -336,617 (-7.19%) | Filing |
| 2023-02-10 12:10 pm Purchase | 2022-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE | Driehaus Capital Management LLC | 4,681,797 7.490% | 1,558,568 (+49.90%) | Filing |
| 2022-02-14 09:14 am Purchase | 2021-12-31 | 13G | Xenon Pharmaceuticals Inc. XENE | Driehaus Capital Management LLC | 3,123,229 6.050% | 3,123,229 (New Position) | Filing |